Literature DB >> 19769804

Review of current theories for abdominal aortic aneurysm pathogenesis.

Ian M Nordon1, Robert J Hinchliffe, Peter J Holt, Ian M Loftus, Matthew M Thompson.   

Abstract

Atherosclerotic plaques are a feature of abdominal aortic aneurysms (AAAs). Atherosclerosis and AAA appear to share similar risk factors. These observations have led to the conclusion that AAAs are a consequence of advanced atherosclerosis.This review explores current theories regarding the pathogenesis of AAA and their implications for treatment.A systematic literature search was conducted using the search terms abdominal aortic aneurysm, atherosclerosis, pathogenesis, and systemic disease. Articles were categorized according to the association of AAAs with atherosclerosis, arteriomegaly, peripheral aneurysm, systemic expression, genetics, autoimmunity, oxidative stress, and systemic disease. Twenty-nine articles reporting changes in the systemic vasculature associated with AAA and 12 articles examining the shared risk factor hypothesis were identified.There is insufficient evidence to confirm that AAAs are the result of advanced atherosclerosis. The bulk of evidence points to AAA disease being a systemic disease of the vasculature, with a predetermined genetic susceptibility leading to a phenotype governed by environmental factors.

Entities:  

Mesh:

Year:  2009        PMID: 19769804     DOI: 10.2310/6670.2009.00046

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  24 in total

1.  Combining two potential causes of metalloproteinase secretion causes abdominal aortic aneurysms in rats: a new experimental model.

Authors:  Karina M Mata; Paula S Prudente; Fabio S Rocha; Cibele M Prado; Elaine M Floriano; Jorge Elias; Elen Rizzi; Raquel F Gerlach; Marcos A Rossi; Simone G Ramos
Journal:  Int J Exp Pathol       Date:  2010-10-29       Impact factor: 1.925

2.  Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.

Authors:  Yanwen Qin; Xu Cao; Jun Guo; Yaozhong Zhang; Lili Pan; Hongjia Zhang; Huihua Li; Chaoshu Tang; Jie Du; Guo-Ping Shi
Journal:  Cardiovasc Res       Date:  2012-08-07       Impact factor: 10.787

3.  Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm.

Authors:  Zhenjie Liu; Stephanie Morgan; Jun Ren; Qiwei Wang; Douglas S Annis; Deane F Mosher; Jing Zhang; Christine M Sorenson; Nader Sheibani; Bo Liu
Journal:  Circ Res       Date:  2015-05-04       Impact factor: 17.367

4.  Protective role of the matricellular protein CCN3 in abdominal aortic aneurysm.

Authors:  Pavel Uhrin; Johannes M Breuss
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

5.  Emerging roles of CCN proteins in vascular development and pathology.

Authors:  Philip A Klenotic; Chao Zhang; Zhiyong Lin
Journal:  J Cell Commun Signal       Date:  2016-05-30       Impact factor: 5.782

6.  Elevated protein kinase C-δ contributes to aneurysm pathogenesis through stimulation of apoptosis and inflammatory signaling.

Authors:  Stephanie Morgan; Dai Yamanouchi; Calvin Harberg; Qiwei Wang; Melissa Keller; Yi Si; William Burlingham; Stephen Seedial; Justin Lengfeld; Bo Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-09       Impact factor: 8.311

7.  Advanced Glycation End Products and its Soluble Receptors in the Pathogenesis of Thoracic Aortic Aneurysm.

Authors:  Kailash Prasad; Abdullah Sarkar; Mohammad A Zafar; Ahmed Shoker; Hamdi Ei Moselhi; Maryann Tranquilli; Bulat A Ziganshin; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2016-02-01

8.  Matricellular protein CCN3 mitigates abdominal aortic aneurysm.

Authors:  Chao Zhang; Dustin van der Voort; Hong Shi; Rongli Zhang; Yulan Qing; Shuichi Hiraoka; Minoru Takemoto; Koutaro Yokote; Joseph V Moxon; Paul Norman; Laure Rittié; Helena Kuivaniemi; G Brandon Atkins; Stanton L Gerson; Guo-Ping Shi; Jonathan Golledge; Nianguo Dong; Bernard Perbal; Domenick A Prosdocimo; Zhiyong Lin
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

9.  Quantification of abdominal aortic aneurysm stiffness using magnetic resonance elastography and its comparison to aneurysm diameter.

Authors:  Arunark Kolipaka; Venkata Sita Priyanka Illapani; William Kenyhercz; Joshua D Dowell; Michael R Go; Jean E Starr; Patrick S Vaccaro; Richard D White
Journal:  J Vasc Surg       Date:  2016-04-27       Impact factor: 4.268

10.  Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.

Authors:  Yasunori Iida; Baohui Xu; Haojun Xuan; Keith J Glover; Hiroki Tanaka; Xiaolei Hu; Naoki Fujimura; Wei Wang; Joshua R Schultz; Court R Turner; Ronald L Dalman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.